F. L. Gersh and C. J. Lavie, Menopause and hormone replacement therapy in the 21st century, Heart, vol.106, pp.479-81, 2020.

P. Y. Scarabin, M. Alhenc-gelas, and G. Plu-bureau, Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial, Arterioscler Thromb Vasc Biol, vol.17, pp.3071-3079, 1997.

P. Scarabin, E. Oger, and G. Plu-bureau, Differential association of oral and transdermal oestrogenreplacement therapy with venous thromboembolism risk, Lancet, vol.362, pp.428-460, 2003.
URL : https://hal.archives-ouvertes.fr/hal-01026273

P. Scarabin, Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis, Climacteric, vol.21, pp.341-346, 2018.